NMR Structure(hide GO term definitions)
Chain A ( SUMO1_HUMAN | P63165)
molecular function |
| GO:0044325 | | ion channel binding | | Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient. |
| GO:0015459 | | potassium channel regulator activity | | Modulates potassium channel activity via direct interaction interaction with a potassium channel (binding or modification). |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0031386 | | protein tag | | A molecular function exhibited by a protein that is covalently attached (AKA tagged or conjugated) to another protein where it acts as a marker, recognized by the cellular apparatus to target the tagged protein for some cellular process such as modification, sequestration, transport or degradation. |
| GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
biological process |
| GO:0006281 | | DNA repair | | The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway. |
| GO:0030578 | | PML body organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of PML bodies, a class of nuclear body; they react against SP100 auto-antibodies (PML = promyelocytic leukemia). |
| GO:0006303 | | double-strand break repair via nonhomologous end joining | | The repair of a double-strand break in DNA in which the two broken ends are rejoined with little or no sequence complementarity. Information at the DNA ends may be lost due to the modification of broken DNA ends. This term covers instances of separate pathways, called classical (or canonical) and alternative nonhomologous end joining (C-NHEJ and A-NHEJ). These in turn may further branch into sub-pathways, but evidence is still unclear. |
| GO:0070911 | | global genome nucleotide-excision repair | | The nucleotide-excision repair process in which DNA lesions are removed from nontranscribed strands and from transcriptionally silent regions over the entire genome. |
| GO:0043392 | | negative regulation of DNA binding | | Any process that stops or reduces the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). |
| GO:0045759 | | negative regulation of action potential | | Any process that stops, prevents, or reduces the frequency, rate or extent of action potential creation, propagation or termination. This typically occurs via modulation of the activity or expression of voltage-gated ion channels. |
| GO:1902260 | | negative regulation of delayed rectifier potassium channel activity | | Any process that stops, prevents or reduces the frequency, rate or extent of delayed rectifier potassium channel activity. |
| GO:0043433 | | negative regulation of sequence-specific DNA binding transcription factor activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0060021 | | palate development | | The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities. |
| GO:1901896 | | positive regulation of calcium-transporting ATPase activity | | Any process that activates or increases the frequency, rate or extent of calcium-transporting ATPase activity. |
| GO:0032436 | | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
| GO:0031334 | | positive regulation of protein complex assembly | | Any process that activates or increases the frequency, rate or extent of protein complex assembly. |
| GO:0090204 | | protein localization to nuclear pore | | A process in which a protein is transported to, or maintained in, a nuclear pore. |
| GO:0050821 | | protein stabilization | | Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. |
| GO:0016925 | | protein sumoylation | | The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxyl terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein. |
| GO:1903169 | | regulation of calcium ion transmembrane transport | | Any process that modulates the frequency, rate or extent of calcium ion transmembrane transport. |
| GO:0086004 | | regulation of cardiac muscle cell contraction | | Any process that modulates the frequency, rate or extent of cardiac muscle cell contraction. |
| GO:0060334 | | regulation of interferon-gamma-mediated signaling pathway | | Any process that modulates the rate, frequency or extent of the series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor. |
| GO:0032880 | | regulation of protein localization | | Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location. |
| GO:0031647 | | regulation of protein stability | | Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation. |
| GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0016032 | | viral process | | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
cellular component |
| GO:0016605 | | PML body | | A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection. |
| GO:0001741 | | XY body | | A structure found in a male mammalian spermatocyte containing an unpaired X chromosome that has become densely heterochromatic, silenced and localized at the nuclear periphery. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0030425 | | dendrite | | A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| GO:0001650 | | fibrillar center | | A structure found most metazoan nucleoli, but not usually found in lower eukaryotes; surrounded by the dense fibrillar component; the zone of transcription from multiple copies of the pre-rRNA genes is in the border region between these two structures. |
| GO:0000792 | | heterochromatin | | A compact and highly condensed form of chromatin. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| GO:0016604 | | nuclear body | | Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins. |
| GO:0031965 | | nuclear membrane | | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
| GO:0005643 | | nuclear pore | | Any of the numerous similar discrete openings in the nuclear envelope of a eukaryotic cell, where the inner and outer nuclear membranes are joined. |
| GO:0016607 | | nuclear speck | | A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. |
| GO:0005730 | | nucleolus | | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| GO:0045202 | | synapse | | The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. |
| GO:0008076 | | voltage-gated potassium channel complex | | A protein complex that forms a transmembrane channel through which potassium ions may cross a cell membrane in response to changes in membrane potential. |
Chain B ( DAXX_HUMAN | Q9UER7)
molecular function |
| GO:0050681 | | androgen receptor binding | | Interacting selectively and non-covalently with an androgen receptor. |
| GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| GO:0031072 | | heat shock protein binding | | Interacting selectively and non-covalently with a heat shock protein, any protein synthesized or activated in response to heat shock. |
| GO:0042393 | | histone binding | | Interacting selectively and non-covalently with a histone, any of a group of water-soluble proteins found in association with the DNA of eukaroytic chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity. |
| GO:0002039 | | p53 binding | | Interacting selectively and non-covalently with one of the p53 family of proteins. |
| GO:0047485 | | protein N-terminus binding | | Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| GO:0030295 | | protein kinase activator activity | | Binds to and increases the activity of a protein kinase, an enzyme which phosphorylates a protein. |
| GO:0019901 | | protein kinase binding | | Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| GO:0005057 | | signal transducer activity, downstream of receptor | | Conveys a signal from an upstream receptor or intracellular signal transducer, converting the signal into a form where it can ultimately trigger a change in the state or activity of a cell. |
| GO:0003714 | | transcription corepressor activity | | Interacting selectively and non-covalently with a repressing transcription factor and also with the basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery. |
| GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
biological process |
| GO:0030578 | | PML body organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of PML bodies, a class of nuclear body; they react against SP100 auto-antibodies (PML = promyelocytic leukemia). |
| GO:0007257 | | activation of JUN kinase activity | | The initiation of the activity of the inactive enzyme JUN kinase (JNK). |
| GO:0030521 | | androgen receptor signaling pathway | | Any series of molecular signals generated as a consequence of an androgen binding to its receptor. |
| GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| GO:0071454 | | cellular response to anoxia | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating a decline in oxygen levels to trace amounts, <0.1%. |
| GO:0071356 | | cellular response to tumor necrosis factor | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
| GO:0006338 | | chromatin remodeling | | Dynamic structural changes to eukaryotic chromatin occurring throughout the cell division cycle. These changes range from the local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation. |
| GO:0008625 | | extrinsic apoptotic signaling pathway via death domain receptors | | A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered. |
| GO:0010832 | | negative regulation of myotube differentiation | | Any process that decreases the frequency, rate or extent of myotube differentiation. Myotube differentiation is the process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse. |
| GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0006334 | | nucleosome assembly | | The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA. |
| GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| GO:0033129 | | positive regulation of histone phosphorylation | | Any process that activates or increases the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein. |
| GO:1901216 | | positive regulation of neuron death | | Any process that activates or increases the frequency, rate or extent of neuron death. |
| GO:0045860 | | positive regulation of protein kinase activity | | Any process that activates or increases the frequency, rate or extent of protein kinase activity. |
| GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| GO:0031396 | | regulation of protein ubiquitination | | Any process that modulates the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0010038 | | response to metal ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus. |
| GO:0006351 | | transcription, DNA-templated | | The cellular synthesis of RNA on a template of DNA. |
| GO:0016032 | | viral process | | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
cellular component |
| GO:0016605 | | PML body | | A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection. |
| GO:0070603 | | SWI/SNF superfamily-type complex | | A protein complex that contains an ortholog of the Saccharomyces ATPase Swi2/Snf2 as one of the core components and mediates assembly of nucleosomes, changes to the spacing or structure of nucleosomes, or some combination of those activities in a manner that requires ATP. |
| GO:0001741 | | XY body | | A structure found in a male mammalian spermatocyte containing an unpaired X chromosome that has become densely heterochromatic, silenced and localized at the nuclear periphery. |
| GO:0044297 | | cell body | | The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections. |
| GO:0005938 | | cell cortex | | The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins. |
| GO:0005694 | | chromosome | | A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information. |
| GO:0000775 | | chromosome, centromeric region | | The region of a chromosome that includes the centromeric DNA and associated proteins. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0005874 | | microtubule | | Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle. |
| GO:0043005 | | neuron projection | | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| GO:0005730 | | nucleolus | | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
|